BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//ifos2026//TCM9XA
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-39BUGK@sciencenext.org
DTSTART;TZID=EET:20260910T150000
DTEND;TZID=EET:20260910T160000
DESCRIPTION:<h3 style="margin-left: 0px!important\;"><strong>Description</s
 trong></h3><p style="margin-left: 0px!important\;">This session reviews th
 e critical molecular landscape of head and neck squamous cell carcinoma (H
 NSCC). We will examine key genetic alterations and signaling pathways\, in
 cluding TP53\, NOTCH1\, and EGFR/PI3K. The presentation highlights how the
 se genetic drivers influence tumor progression\, metastasis\, and resistan
 ce to current treatment modalities\, offering a snapshot of the current ge
 nomic understanding of the disease.</p><h3 style="margin-left: 0px!importa
 nt\;"><strong>Outcome Objectives</strong></h3><ol><li><p style="margin-lef
 t: 0px!important\;">Identify major genetic mutations and chromosomal alter
 ations associated with head and neck cancer.</p></li><li><p style="margin-
 left: 0px!important\;">Understand the relationship between specific geneti
 c pathways and clinical disease behavior.</p></li><li><p style="margin-lef
 t: 0px!important\;">Evaluate the potential of these genetic pathways as ta
 rgets for future precision medicine and therapeutic interventions.</p></li
 ></ol><h3 style="margin-left: 0px!important\;"><strong>Background</strong>
 </h3><p style="margin-left: 0px!important\;">Head and neck cancer exhibits
  significant molecular heterogeneity\, which often complicates treatment a
 nd prognosis. While traditional risk factors are well-known\, the underlyi
 ng genetic mechanisms driving carcinogenesis are complex. Elucidating thes
 e genetic pathways is essential for developing novel biomarkers and target
 ed therapies\, ultimately aiming to improve survival rates and reduce trea
 tment-related morbidity.</p>
DTSTAMP:20260618T223146Z
LOCATION:Humanitarian + Transverse Activities + Global Outreach
SUMMARY:The genetic pathways of head and neck cancer - Ömer Bayır\, SEDA 
 TÜRKOĞLU BABAKURBAN\, Elif Ersoy Callioglu\, Fatih Tetik
URL:https://sciencenext.org/ifos2026/talk/39BUGK/
END:VEVENT
END:VCALENDAR